Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Acting Antiviral Agents”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02607735
What this trial is testing

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy

Who this might be right for
Hepatitis C
Gilead Sciences 416
Not applicableStudy completedNCT01508130
What this trial is testing

An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 672
Not applicableStudy completedNCT03740906
What this trial is testing

Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 202
Post-approval studies (Phase 4)Ended earlyNCT03208127
What this trial is testing

DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant

Who this might be right for
End Stage Liver DiseaseHepatitis C
Massachusetts General Hospital 33
Not applicableUnknownNCT03895294
What this trial is testing

Effect of Strategies for the Treatment of Chronic Hepatitis C in Colombia

Who this might be right for
Hepatitis C
Universidad de Antioquia 124
Not applicableStudy completedNCT02578693
What this trial is testing

Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 1,210
Post-approval studies (Phase 4)Ended earlyNCT03625687
What this trial is testing

Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant

Who this might be right for
Respiratory FailureHepatitis C
Massachusetts General Hospital 19
Testing effectiveness (Phase 2)Study completedNCT01878799
What this trial is testing

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Who this might be right for
Hepatitis CHIV
National Institute of Allergy and Infectious Diseases (NIAID) 50
Post-approval studies (Phase 4)Study completedNCT03250910
What this trial is testing

Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
National Taiwan University Hospital 228
Not applicableStudy completedNCT07702396
What this trial is testing

Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease

Who this might be right for
Heptatitis C
Indus Hospital and Health Network 192
Very early researchStudy completedNCT03188276
What this trial is testing

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 52
Not applicableStudy completedNCT04330508
What this trial is testing

Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial

Who this might be right for
Depression in Chronic Hepatitis C
Post Graduate Institute of Medical Education and Research, Chandigarh 385
Not applicableStudy completedNCT04719338
What this trial is testing

Occult HCV Infection After DAAD Treatment in Haemodialysis Patients

Who this might be right for
Hepatitis C
Alexandria University 30
Not applicableUnknownNCT05284916
What this trial is testing

Difference in Patterns of Liver Diseases Related Admissions After the Era of DAAS

Who this might be right for
Patternsof Liver Diseasesadmissions After Era of DAAS
Sohag University 200
Not applicableUnknownNCT03897608
What this trial is testing

Quality of Life in Patients With HCV Related Liver Cirrhosis Before and After Direct Acting Antiviral Drugs

Who this might be right for
HCV Related Liver Cirrhosis Direct Acting Antiviral Drugs
Assiut University 50
Not applicableActive Not RecruitingNCT07565948
What this trial is testing

Sofosbuvir/Velpatasvir/Voxilaprevir Salvage Therapy in Hepatitis C Patients Who Relapsed After DAA Treatment

Who this might be right for
Hepatitis C Virus (HCV)
Xiangya Hospital of Central South University 200
Not applicableStudy completedNCT02758509
What this trial is testing

Impact of Antiviral Therapy on Gastroesophageal Varices.

Who this might be right for
Chronic Hepatitis CCirrhosis
Parc de Salut Mar 237
Testing effectiveness (Phase 2)Study completedNCT02868242
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 19
Post-approval studies (Phase 4)Study completedNCT04457050
What this trial is testing

Effect of Hepatitis C Clearance on Insulin Resistance

Who this might be right for
Insulin ResistanceHepatitis C
Alexandria University 160
Early research (Phase 1)Study completedNCT02185794
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 101
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation